drug · small molecule
TP-05
Phase 2updated 3mo agoby $TARS Tarsus Pharmaceuticals, Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for nasopharyngeal carcinoma and eye infection and 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying TP-05
- phase2A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
- phase2Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
- phase4Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
- phase2A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
- phase3Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
- phase1A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects
- phase2Study of TP-04 in Participants With Papulopustular Rosacea
- phase1Study to Evaluate the Food Effect of TP-05 in Healthy Participants
News(1)
- Tarsus pays $450M for Alkeus and its phase 3-stage retinal disease drugTarsus Pharmaceuticals is fronting $450 million to acquire Alkeus Pharmaceuticals for its phase 3-stage retinal disease therapy that's being touted as a potential blockbuster.fiercebiotech · 9d ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that